✦ LIBER ✦

Biomarkers of cell death applicable to early clinical trials

✍ Scribed by Emma Dean; Alastair Greystoke; Malcolm Ranson; Caroline Dive

Book ID: 113956232
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 384 KB
Volume: 318
Category: Article
ISSN: 0014-4827
DOI: 10.1016/j.yexcr.2012.03.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Application of Biomarkers to Clinical Tr

Application of Biomarkers to Clinical Trials in Systemic Sclerosis

✍ Robert Lafyatis 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 160 KB

Anticonvulsant trials not applicable to

Anticonvulsant trials not applicable to clinical practice

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 266 KB

Circulating tumor cells as pharmacodynam

Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials

✍ Lot A. Devriese; Emile E. Voest; Jos H. Beijnen; Jan H.M. Schellens 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB

From Darkness to Light With Biomarkers i

From Darkness to Light With Biomarkers in Early Clinical Trials of Cancer Drugs

✍ Carden, CP; Banerji, U; Kaye, SB; Workman, P; de Bono, JS 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 122 KB

Identification of synovial biomarkers of

Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis

✍ Elli Kruithof; Leen De Rycke; Bernard Vandooren; Filip De Keyser; Oliver FitzGer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB 👁 1 views

Optimisation of circulating biomarkers o

Optimisation of circulating biomarkers of cell death for routine clinical use

✍ Greystoke, A.; Cummings, J.; Ward, T.; Simpson, K.; Renehan, A.; Butt, F.; Moore 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 200 KB